Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Product type
Topic
- Safety monitoring and information (122)
- Compliance and enforcement (32)
- Import and export (28)
- Shortages and supply disruptions (17)
- Sunscreens (7)
- Advertising (6)
- COVID-19 (5)
- Labelling and packaging (4)
- Weight loss products (4)
- Breast implant hub (3)
- Manufacturing (3)
- Legislation (2)
- Metal-on-metal hip replacement implants hub (1)
Type of content
Search
9 result(s) found, displaying 1 to 9
-
Medicine shortage alertsAll strengths of the Mounjaro vial presentation are discontinued but the Mounjaro KwikPen is available in the same strengths.
-
Medicine shortage alertsWe have approved overseas-registered substitutes for Pegasys 135 micrograms/0.5 mL and 180 micrograms/0.5 mL pre-filled syringes.
-
Safety alertsMore prominent warnings are being added to the Product Information and Consumer Medicine Information for all oral and injectable (systemic) fluoroquinolones to strengthen existing warnings about serious side effects.
-
Safety alertsExtra safety information is being added to all montelukast products to highlight the existing warnings about serious behaviour and mood-related changes
-
Market actionsThere have been reports of the dose counter stopping after the 10th dose and not locking after the 60th dose. If this happens, you should return the product to your place of purchase or contact Boehringer Ingelheim.
-
Safety alertsThere are new warnings about the risks of heart attack and stroke with taking romosozumab (Evenity). The Product Information (PI) and Consumer Medicine Information (CMI) have been updated to reflect these risks.
-
Safety alertsOur safety advisory includes information for consumers and health professionals about low levels of nitrosamine impurity in medicines containing sitagliptin.
-
Safety alertsTGA investigation - potential low levels of contamination with N-nitrosovarenicline
-